Open AccessSuccessful treatment of infantile hepatitis B with lamivudine: A case report
Author(s) -
Yuting Zhang,
Jing Liu,
XiaoBen Pan,
Yidan Gao,
Yin-Fei Hu,
Lin Li,
Hua-Jun Cheng,
Gong-Ying Chen
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i14.3442
Subject(s) - medicine , lamivudine , hepatitis b , virology , pediatrics , hepatitis b virus , dermatology , gastroenterology , virus
How to treat infantile hepatitis B virus (HBV) infection remains a controversial issue. The nucleoside analogue lamivudine (LAM) has been approved to treat children (2 to 17 years old) with chronic hepatitis B. Here, we aimed to investigate the benefit of LAM treatment in infantile hepatitis B.